Effects of a student pharmacist consultation on patient knowledge and attitudes about vaccines

Journal of the American Pharmacists Association (Impact Factor: 1.24). 03/2014; 54(2):130-7. DOI: 10.1331/JAPhA.2014.13114
Source: PubMed

ABSTRACT OBJECTIVE To measure the impact of student pharmacists' consultation on participant knowledge and attitudes about influenza and tetanus-diphtheria-acellular pertussis (Tdap) vaccines. DESIGN Pre- and post-consultation surveys. SETTING Free health care service and immunization clinics in Vallejo and Martinez, CA. PARTICIPANTS Children and adults 13 years of age or older. INTERVENTION A convenience sample of participants completed a preintervention survey (PrIs) on basic vaccine knowledge and attitudes. Student pharmacists then delivered the intervention, which consisted of a 5-minute consultation on vaccines. A postintervention (PoIs) survey was administered immediately after the intervention. MAIN OUTCOME MEASURES Cumulative scores for eight knowledge-based questions and four attitude-based questions. RESULTS 198 participants completed both PrIs and PoIs. Compared with the PrI scores, the PoI scores showed significant improvement in basic vaccine knowledge and attitudes toward receiving vaccinations. Participants also were more likely to view pharmacists as a source of information about vaccines after the intervention. Student pharmacists administered 109 total vaccinations during the study, including 68 influenza vaccinations and 41 Tdap vaccinations. CONCLUSION A short, 5-minute consultation by a student pharmacist may increase vaccination rates and help serve as a vehicle to change the public's view of vaccines as well as pharmacists and their role in primary and preventive care.

4 Reads
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: To determine if a community-based intervention program focusing on parenting education will have an impact on preventive health care utilization behaviors among low-income, minority mothers in Washington, DC. The experimental design was a randomized, controlled study in which 286 mother-infant dyads were assigned to either the standard social services (control) group or to the intervention group. Women and their newborn infants were recruited during the immediate postpartum period in 4 Washington, DC, hospital sites from April 1995 to April 1997. The year-long multicomponent intervention included home visits and hospital-based group sessions in addition to the standard social services available at the hospital sites. A total of 286 postpartum women with inadequate prenatal care were assigned randomly to the control or the intervention group. Women and their infants were followed for 1 full year. Outcome measures included usage of preventive health care services including well care infant visits and adherence to immunization schedules during the first year of the infant's life. Infants in the intervention group initiated well care at an earlier age than controls (by 6 weeks, 62.5% vs 50% had received their first well infant visit). Infants in the intervention group had more frequent well visits (by 12 months of age, 3.5 vs 2.7 visits). Multivariate analyses showed infants in the intervention group to be more likely to complete their scheduled immunizations (by 9 months, odds ratio = 2.2, 95% confidence interval: 1.09-4.53). Those in the intervention group with more frequent contacts (30+ visits) with study personnel were most likely to have followed age-appropriate immunization schedules when compared with controls (at 9 months odds ratio = 3.63, 95% confidence interval: 1.58-8.33). It is possible to influence health care usage patterns of high-risk minority populations through public health interventions that are global in their perspective. Focusing on parental knowledge and beliefs regarding health-related issues and life skills in a self-efficacy model is associated with improved usage of infant health care resources.
    PEDIATRICS 07/2003; 111(6 Pt 1):1324-32. DOI:10.1542/peds.111.6.1324 · 5.47 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Blood pressure (BP) control in patients with diabetes mellitus is difficult to achieve and current patterns are suboptimal. Given increasing problems with access to primary care physicians, community pharmacists and nurses are well positioned to identify and observe these patients. This study aimed to determine the efficacy of a community-based multidisciplinary intervention on BP control in patients with diabetes mellitus. We performed a randomized controlled trial in 14 community pharmacies in Edmonton, Alberta, Canada, of patients with diabetes who had BPs higher than 130/80 mm Hg on 2 consecutive visits 2 weeks apart. Care from a pharmacist and nurse team included a wallet card with recorded BP measures, cardiovascular risk reduction education and counseling, a hypertension education pamphlet, referral to the patient's primary care physician for further assessment or management, a 1-page local opinion leader-endorsed evidence summary sent to the physician reinforcing the guideline recommendations for the treatment of hypertension and diabetes, and 4 follow-up visits throughout 6 months. Control-arm patients received a BP wallet card, a pamphlet on diabetes, general diabetes advice, and usual care by their physician. The primary outcome measure was the difference in change in systolic BP between the 2 groups at 6 months. A total of 227 eligible patients were randomized to intervention and control arms between May 5, 2005, and September 1, 2006. The mean (SD) patient age was 64.9 (12.1) years, 59.9% were male, and the mean (SD) baseline systolic/diastolic BP was 141.2 (13.9)/77.3 (8.9) mm Hg at baseline. The intervention group had an adjusted mean (SE) greater reduction in systolic BP at 6 months of 5.6 (2.1) mm Hg compared with controls (P = .008). In the subgroup of patients with a systolic BP greater than 160 mm Hg at baseline, BP was reduced by an adjusted mean (SE) of 24.1 (1.9) mm Hg more in intervention patients than in controls (P < .001). Even in patients who have diabetes and hypertension that are relatively well controlled, a pharmacist and nurse team-based intervention resulted in a clinically important improvement in BP. Trial Registration Identifier: NCT00374270.
    Archives of internal medicine 12/2008; 168(21):2355-61. DOI:10.1001/archinte.168.21.2355 · 17.33 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: OBJECTIVES To assess patient knowledge about H1N1 influenza pandemic and vaccine availability, evaluate the effectiveness of student pharmacist education about H1N1 influenza, assess patient comfort with pharmacists as immunization providers, and identify patients preferred location for H1N1 vaccination. DESIGN Descriptive, nonexperimental, cross-sectional study. SETTING 18 community pharmacy advanced pharmacy practice experience (CP-APPE) sites located across New York State, from September 2009 to February 2010. PARTICIPANTS Convenience sample of adult (≥18 years of age) patients of CP-APPE sites. INTERVENTION Student pharmacists delivered an education intervention to patients and patients completed anonymous surveys. MAIN OUTCOME MEASURES Patient knowledge and comfort with pharmacists as immunizers. RESULTS 19 student pharmacists at 18 CP-APPE sites engaged in 215 interventions. The majority of respondents were women (60.9%) who were older than 60 years (43.7%) and white (83.7%). Patient knowledge and comfort with pharmacists as immunizers improved significantly. Compared with baseline, student pharmacist education interventions significantly increased the number of patients who were comfortable receiving the H1N1 influenza vaccination from a pharmacist (from 69.3% to 81.4%, P = 0.012). CONCLUSION Student pharmacists served as an effective education resource for patients regarding the H1N1 pandemic. Patient comfort with pharmacist provision of the H1N1 vaccination can enable pharmacists to serve as frontline health professionals in the time of a pandemic outbreak.
    Journal of the American Pharmacists Association 11/2012; 52(6):763-7. DOI:10.1331/JAPhA.2012.11003 · 1.24 Impact Factor